Navigation Links
Auxilium Pharmaceuticals, Inc. to Present At The JMP Securities 2012 Healthcare Conference
Date:7/6/2012

ase clostridium histolyticum) in 46 countries in Eurasia; Asahi Kasei Pharma Corporation has development and commercial rights for XIAFLEX in Japan; and Actelion Pharmaceuticals Ltd has development and commercial rights for XIAFLEX in Canada, Australia, Brazil and Mexico.  Auxilium has three projects in clinical development. XIAFLEX is in phase III of development for the treatment of Peyronie's Disease. Collagenase clostridium histolyticum ("CCH") is in phase IIa of development for the treatment of Frozen Shoulder syndrome (adhesive capsulitis) and phase Ib of development for the treatment of cellulite (edematous fibrosclerotic panniculopathy). Auxilium also has rights to pursue additional indications for CCH. For additional information, visit http://www.auxilium.com

SAFE HARBOR STATEMENT UNDER THE PRIVATE SECURITIES LITIGATION REFORM ACT OF 1995This release contains "forward-looking-statements" within the meaning of The Private Securities Litigation Reform Act of 1995, including statements regarding the Company's intention to present at the JMP Securities Global Healthcare Conference 2012; and products in development for Peyronie's disease, Frozen Shoulder syndrome and cellulite; and all other statements containing projections, statements of future performance or expectations, our beliefs or statements of plans or objectives for future operations (including statements of assumption underlying or relating to any of the foregoing). Forward-looking statements can generally be identified by words such as "believe," "appears," "may," "could," "will," "estimate," "continue," "anticipate," "intend," "should," "plan," "expect," and other words and terms of similar meaning in connection with any discussion of projections, future performance or expectations, beliefs, plans or objectives for future operations (including statements of assumption underlying or relating to any of the foregoing). Actual results may differ materia
'/>"/>

SOURCE Auxilium Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. Auxilium Pharmaceuticals, Inc. to Present at the Jefferies 2012 Global Healthcare Conference
2. Auxilium Announces Appointments to Enhance Leadership Team
3. Silence Therapeutics Partner, Quark Pharmaceuticals, Extends its Agreement With Pfizer to Develop one of Its Compounds Containing Silences AtuRNAi in a New Indication
4. Synergy Pharmaceuticals, Inc. Files Suit Against Ironwood Pharmaceuticals, Inc. and its Chief Scientific Officer and Senior VP of R&D, Dr. Mark G. Currie
5. Keryx Biopharmaceuticals, Inc. Announces Upcoming Poster Presentations of Zerenex™ (Ferric Citrate) at the Upcoming American Society of Nephrology Kidney Week 2011 Annual Meeting
6. InspireMD to Present at JMP Securities Healthcare Conference on July 12th in New York
7. InspireMD to Present at JMP Securities Healthcare Conferenceon July 12th in New York
8. Sangamo BioSciences Announces Presentation at Seventh Annual JMP Securities Healthcare Conference
9. UAS Laboratories Presents about Probiotic Selection Criteria, at Scientific Conference
10. Data From Phase II Trial of Prolor Biotechs Long-acting Human Growth Hormone Presented at Endo 2012
11. Frost & Sullivan Presents 2012 Clinical Diagnostics Company of the Year Award to GenPath Diagnostics of BioReference Laboratories, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... 2013  Superior Controls, Inc. has been named ... NH Magazine.  For the past 22 years, the ... themselves with extraordinary business and civic excellence. ... honor," said Rick Pierro , ... this award is a reflection of Superior Controls, ...
(Date:5/22/2013)... (PRWEB) May 22, 2013 Genedata, ... industrial biotechnology, drug discovery, and life science research, ... Selector ™ as its bioinformatics platform for ... organisms. Genedata will provide AB Enzymes, one of ... a hosted solution of Genedata Selector accompanied by ...
(Date:5/22/2013)... 2013 AudioNotch is ... tinnitus treatment. AudioNotch is pleased to announce a ... locations in both British Columbia and Alberta, Destination ... hearing services. AudioNotch's tinnitus treatment program is now ... a Destination Hearing clinic, patients have the detection ...
(Date:5/22/2013)... (PRWEB) May 22, 2013 Express ... Supplies Pty Ltd are pleased to announce a ... the Australian and New Zealand distributor of DrugCheck® onsite ... Supercar Team participated in the Austin 400 May 17-19 ... into an agreement that involves each car of the ...
Breaking Biology Technology:Superior Controls of Seabrook, NH named Business of the Year for 2013 by Business NH Magazine 2AB Enzymes Chooses Genedata Selector for Production Strain Development and Optimization 2AB Enzymes Chooses Genedata Selector for Production Strain Development and Optimization 3AB Enzymes Chooses Genedata Selector for Production Strain Development and Optimization 4AudioNotch Tinnitus Treatment Launches Partnership With Destination Hearing 2Australian Distributor of Express Diagnostics Signs Sponsorship Agreement with V8 Supercar Team 2
... , , BELLE ... construction in Northern New Jersey will streamline and improve the quality ... ( http://www.hi-consult i ng.net ), a leader ... Mead-based firm was selected to oversee all aspects of practice management ...
... , , WESTON, Fla., Aug. 19 ... greatly benefit the wellbeing of families, America n ... today announced it has obtained from Safeguard Medical Technologies, LLC exclusive ... known as the Disintegrator(TM) and the Disintegrator Plus(TM). , ...
... , , , ... indirect land use study - Searchinger et al. - found ... and Dr. Hao Tan, researchers from Macquarie University in Sydney, Australia, undertook ... the framework used was inappropriate in that it started with assumptions as ...
Cached Biology Technology:New Jersey Surgery Centers Pick Health Informatics Consulting to Implement Patient Electronic Health Record Systems 2American Scientific Resources To Be Exclusive Seller of World's Only FDA Approved Home Needle Destruction Device 2American Scientific Resources To Be Exclusive Seller of World's Only FDA Approved Home Needle Destruction Device 3Analysis of Biofuels Indirect Land Use Effects Finds the Science Lacking: 'Too Diffuse and Subject To Too Many Arbitrary Assumptions To Be Useful for Rule-making.' 2Analysis of Biofuels Indirect Land Use Effects Finds the Science Lacking: 'Too Diffuse and Subject To Too Many Arbitrary Assumptions To Be Useful for Rule-making.' 3
(Date:5/21/2013)... whale entangled in fishing gear, scientists showed for the ... and swimming behavior. The monitoring revealed how fishing gear ... energy as they drag gear for months or years, ... scientists in this entanglement response suction-cupped a cellphone-size device ... right whale called Eg 3911. The Dtag, developed at ...
(Date:5/21/2013)... researchers have developed a new method for delivering ... in the cell surface. The technique could find ... biological fields. , Bulk electroporation a technique ... nanopores in the cell membrane that are caused ... an increasingly popular method of cell transfection. (Cell ...
(Date:5/21/2013)... shape is an uphill battle? Try staying fit in ... withers muscle and bone. , That,s the challenge a ... a new three-year, $1.2 million grant from NASA. Their ... multiyear exploratory missions. , "You could give astronauts the ... get them to stick to it, it isn,t going ...
Breaking Biology News(10 mins):Study reveals how fishing gear can cause slow death of whales 2Study reveals how fishing gear can cause slow death of whales 3Single-cell transfection tool enables added control for biological studies 2Fueling fitness on the final frontier 2
... -- We love it fresh, canned and frozen. It,s grown ... by the American Society of Horticultural Science, adds up to ... In other words, sweet corn is big business. Fresh ... July, with only ten percent of the annual volume marketed ...
... an advanced online publication in the journal Nature revealed a ... of lung cancer that is the most common cause of ... was a specific proto-oncogene called NKX2-1 that appears involved in ... most common cause of cancer deaths worldwide, said the ...
... 2, 2007 - Oakland, CA -- A new study ... Elizabeth Theil, Ph.D., is the first to suggest that ... into one unit) could be used to accelerate the ... this study may help scientists develop new medications that ...
Cached Biology News:How sweet is it? 2Tumor genome analysis unveils new insights into lung cancer 2Tumor genome analysis unveils new insights into lung cancer 3
... of optimized cell lines in combination with ... parameters. Nucleofector Kits are only functional in ... lines can be transfected with this kit. ... in brackets in percent (Efficiency [%] / ...
... brings together UV irradiation and antimicrobial stainless ... PCR contamination! Quickly inactivate DNA between ... clean environment with antimicrobial coated stainless steel ... minutes with built-in 30-minute timer ...
... Varioskan is a high performance ... dispenser and incubator. With the advanced ... and reliability for drug discovery assay ... for fluorescence intensity, time-resolved fluorescence and ...
Strip Removal Tool 25/Box...
Biology Products: